Haemonetics (HAE) PT Raised to $142 at Needham & Company, Following Earnings
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.55 -0.86%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Needham & Company analyst Mike Matson raised the price target on Haemonetics (NYSE: HAE) to $142.00 (from $138.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Alpha & Omega Semiconductor (AOSL) PT Lowered to $45 at Needham
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Needham & Company, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
